Veeva Systems Inc. (0LO3.L)
USD 217.0
(-1.92%)
USD 217.0
(-1.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 1.25 Billion USD | 15.69% |
| 2023 | 1.08 Billion USD | 29.11% |
| 2022 | 841.6 Million USD | 24.07% |
| 2021 | 678.34 Million USD | 31.85% |
| 2020 | 514.49 Million USD | 30.56% |
| 2019 | 394.06 Million USD | 21.87% |
| 2018 | 323.34 Million USD | 23.23% |
| 2017 | 262.39 Million USD | 39.26% |
| 2016 | 188.41 Million USD | 47.67% |
| 2015 | 127.59 Million USD | 44.6% |
| 2014 | 88.24 Million USD | 107.64% |
| 2013 | 42.49 Million USD | 66.22% |
| 2012 | 25.56 Million USD | 118.14% |
| 2011 | 11.72 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 317.78 Million USD | -0.79% |
| 2024 Q1 | 298.13 Million USD | 2.75% |
| 2024 Q2 | 317.15 Million USD | 6.38% |
| 2024 FY | 1.24 Billion USD | 14.36% |
| 2024 Q3 | 320.33 Million USD | 1.0% |
| 2023 Q3 | 277.04 Million USD | -1.57% |
| 2023 Q1 | 237.91 Million USD | 3.49% |
| 2023 FY | 1.08 Billion USD | 29.11% |
| 2023 Q2 | 281.45 Million USD | 18.3% |
| 2023 Q4 | 290.15 Million USD | 4.73% |
| 2022 Q4 | 229.9 Million USD | 7.51% |
| 2022 Q2 | 208.87 Million USD | 10.52% |
| 2022 Q1 | 188.99 Million USD | 2.67% |
| 2022 FY | 841.6 Million USD | 24.07% |
| 2022 Q3 | 213.83 Million USD | 2.38% |
| 2021 Q4 | 184.07 Million USD | 6.27% |
| 2021 FY | 678.34 Million USD | 31.85% |
| 2021 Q1 | 154.66 Million USD | -1.36% |
| 2021 Q3 | 173.21 Million USD | 4.1% |
| 2021 Q2 | 166.39 Million USD | 7.59% |
| 2020 Q1 | 108.08 Million USD | 3.13% |
| 2020 Q3 | 126.79 Million USD | 3.23% |
| 2020 FY | 514.49 Million USD | 30.56% |
| 2020 Q4 | 156.79 Million USD | 23.66% |
| 2020 Q2 | 122.82 Million USD | 13.64% |
| 2019 FY | 394.06 Million USD | 21.87% |
| 2019 Q4 | 104.79 Million USD | 4.52% |
| 2019 Q3 | 100.26 Million USD | 2.77% |
| 2019 Q2 | 97.56 Million USD | 6.7% |
| 2019 Q1 | 91.43 Million USD | 0.35% |
| 2018 FY | 323.34 Million USD | 23.23% |
| 2018 Q3 | 81.24 Million USD | 2.47% |
| 2018 Q4 | 91.11 Million USD | 12.15% |
| 2018 Q1 | 71.69 Million USD | 0.76% |
| 2018 Q2 | 79.28 Million USD | 10.58% |
| 2017 Q1 | 60.86 Million USD | 2.62% |
| 2017 Q4 | 71.15 Million USD | 9.39% |
| 2017 FY | 262.39 Million USD | 39.26% |
| 2017 Q3 | 65.04 Million USD | -0.44% |
| 2017 Q2 | 65.33 Million USD | 7.33% |
| 2016 Q2 | 42.28 Million USD | 14.23% |
| 2016 Q1 | 37.01 Million USD | 5.23% |
| 2016 FY | 188.41 Million USD | 47.67% |
| 2016 Q4 | 59.31 Million USD | 19.08% |
| 2016 Q3 | 49.8 Million USD | 17.8% |
| 2015 FY | 127.59 Million USD | 44.6% |
| 2015 Q4 | 35.17 Million USD | 5.09% |
| 2015 Q3 | 33.46 Million USD | 8.86% |
| 2015 Q2 | 30.74 Million USD | 8.96% |
| 2015 Q1 | 28.21 Million USD | 3.97% |
| 2014 Q2 | 20.6 Million USD | 21.85% |
| 2014 FY | 88.24 Million USD | 107.64% |
| 2014 Q3 | 23.6 Million USD | 14.57% |
| 2014 Q4 | 27.13 Million USD | 14.98% |
| 2014 Q1 | 16.9 Million USD | 23.72% |
| 2013 Q4 | 13.66 Million USD | 22.49% |
| 2013 Q3 | 11.15 Million USD | 0.0% |
| 2013 FY | 42.49 Million USD | 66.22% |
| 2012 FY | 25.56 Million USD | 118.14% |
| 2011 FY | 11.72 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -239.889% |
| Accuray Incorporated | 142.61 Million USD | -781.415% |
| Align Technology, Inc. | 2.07 Billion USD | 39.473% |
| Elevance Health Inc. | 36.23 Billion USD | 96.531% |
| AxoGen, Inc. | 149.33 Million USD | -741.758% |
| Boston Scientific Corporation | 7.5 Billion USD | 83.253% |
| CVS Health Corporation | 40.68 Billion USD | 96.911% |
| Cardinal Health, Inc. | 5 Billion USD | 74.859% |
| Centene Corporation | 138.33 Billion USD | 99.091% |
| DaVita Inc. | 1.47 Billion USD | 14.718% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 97.234% |
| Hologic, Inc. | 1.26 Billion USD | 0.832% |
| Humana Inc. | 102.36 Billion USD | 98.772% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -15.026% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | 37.813% |
| Masimo Corporation | 867 Million USD | -44.988% |
| McKesson Corporation | 8.67 Billion USD | 85.51% |
| Patterson Companies, Inc. | 1.12 Billion USD | -11.508% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | 21.922% |
| ResMed Inc. | 1.36 Billion USD | 8.136% |
| Henry Schein, Inc. | 2.93 Billion USD | 57.2% |
| Teladoc Health, Inc. | 2.09 Billion USD | 39.881% |
| Universal Health Services, Inc. | 9.2 Billion USD | 86.349% |
| Baxter International Inc. | 5.27 Billion USD | 76.156% |
| Becton, Dickinson and Company | 6.71 Billion USD | 81.272% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 57.571% |
| Danaher Corporation | 8.75 Billion USD | 85.642% |
| Stryker Corporation | 9.2 Billion USD | 86.35% |
| Medtronic plc | 16.12 Billion USD | 92.206% |